(HealthDay News) — Adults with concurrent hypertension and type 2 diabetes (T2D) have high mortality risk compared with those who have neither condition or only one, according to a study published ...
May 27, 2025-- U.S. adults with both hypertension and Type 2 diabetes (T2D) face a significantly higher risk of all-cause and cardiovascular mortality compared to those with only one of these ...
Both the cause and a potential cure for the most common identifiable and specifically treatable cause of hypertension – aldosterone-producing adenomas (APAs) – have been revealed by researchers from ...
Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...
Figure 3. ACE inhibitors and ARBs have different sites of action within the RAS pathway. The solid arrows indicate activation, and the dashed arrows indicate inhibition. ACE = angiotensin-converting ...
Higher all-cause and cardiovascular mortality predicted with concurrent hypertension and type 2 diabetes. (HealthDay News) — Adults with concurrent hypertension and type 2 diabetes (T2D) have high ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results